Skip to main content
Home
language-selector-globe Czech Republic | en
Choose Location
language-selector-globe Czech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Czech Republic
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in the Czech Republic 
      • Strategy 
      • Diversity and inclusion 
      • People and culture 
      • Products 
      • Country leadership team 
      • Our mission and vision 
      • Innovative medicines 
      • Contact 
      Novartis Česká republika About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Our patient portals for Czech Republic 
      • Products 
      • Adverse event reporting 
      • Provision of gifts and grants 
      Babička s vnučkou v objetí Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis pipeline 
      • Adverse event reporting 
      • Novartis clinical trials 
        • Clinical trials in Czech Republic 
      • VPOIS 
      • Expert information 
      Vědec se dívá do mikroskopu Healthcare Professionals
    • Research and development 
      • Research and development in Czech Republic 
      Vědkyně v laboratoři Research and development
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Ethical behavior 
      • Whistleblow line 
      Ruka na rozpukané vyprahlé hlíně ESG
    • News 
      • News archive 
      • Stories 
      • Media library 
      • Media contacts 
      Diskutující lidé s notebooky nad odbornými články News
    • Careers 
      • Career search 
      • Meet the teams 
      • Personal growth 
      • Early talent 
      • How we work 
      • Leadership trainee program 
      • Well-being 
      • Diversity and inclusion 
      • Awards and recognition 
      Usmívající se žena v posluchárně Careers
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu. Coronavirus
    Female scientist in laboratory Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Legal & Intellectual Property & Compl. Oct 17, 2024
Vice President of European Public Affairs Vilvoorde Belgium Corporate Affairs Innovative Medicines Communications & Public Affairs Oct 10, 2024
Vendor Management & Governance Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 18, 2024
Vendor Management & Governance Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 04, 2024
Vendor Alliance Lead Associate Director East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 03, 2024
Value Access Manager Bogota (Oncology) / Cali (Pharmaceuticals) Colombia International Innovative Medicines Market Access Oct 10, 2024
Validation Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 03, 2024
Validation Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Jul 22, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations Aug 19, 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access Oct 18, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Time Service Delivery Expert - CZ, SK & HU Prague Czech Republic People & Organization CTS Human Resources Oct 02, 2024
Third Party Risk Management Specialist Prague Czech Republic Operations CTS Procurement Jul 30, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Lead (ONCO/Hema & NS/Imm) Kyiv Ukraine International Innovative Medicines Commercial & General Management Apr 16, 2024
Therapeutic Data Strategy Director East Hanover USA Development Innovative Medicines Research & Development Jul 02, 2024
Therapeutic Area Partner - Kuwait Kuwait Kuwait International Innovative Medicines Sales Apr 23, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Therapeutic Area Head Hematology (region LACan) East Hanover USA International Innovative Medicines Commercial & General Management Oct 14, 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 28, 2024
Territory Sales Manager Immunology: Moravia Prague Czech Republic International Innovative Medicines Sales Oct 11, 2024
Territory Sales Manager Cardio: Prague Prague Czech Republic International Innovative Medicines Sales Oct 14, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 14, 2024
Territory Business Executive Chandigarh (Territory) India International Innovative Medicines Sales Oct 14, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Apr 16, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines Sales Oct 03, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 04, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 04, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Sep 30, 2024
Territory Business Executive Assam India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Orissa India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 37
  • › Next page

Novartis Czech Republic

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
  • Adverse event reporting
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis websites
  • Global
Footer Bottom
© 2024 Novartis s.r.o
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Czech Republic